Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC

Summary

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of 2 doses of GED-0507-34-Levo in subjects with active, mild-to-moderate UC.

Timeline

Start

2016-11-28

Primary completion

2017-07-31

Completion

2017-07-31

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications